A study assessed the expression of CRISP2 in the spermatozoa and seminal plasma fluid of three groups of infertile men (asthenozoospermia, teratozoospermia, and teratoasthenozoospermia), and then compared with the control (normozoospermic infertile men). Here, CRISP2 is linked to Abnormal sperm morphology.